Trial Profile
Clinical trial of AlloStim (Tm) in patients with metastatic cancer in Thailand
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 07 Jan 2014
Price :
$35
*
At a glance
- Drugs T-cell vaccine-AlloStim (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors Immunovative Therapies
- 07 Jan 2014 New trial record